The Future of Personalized and Targeted Cancer Therapy: Penn Medicine Scientist and Trial Participant Detail Experiences on Leading Edge of Gene Therapy
Perelman School of Medicine at the University of PennsylvaniaHarnessing the patient’s own immune system to fight cancer through genetic modification of their own cells is rapidly emerging as a promising treatment option. Although these therapies provide great opportunities, they also pose unique challenges as investigators seek to refine the approach and expand the treatment option to more patients. A panel discussion at the AACR Annual Meeting 2013 – featuring the University of Pennsylvania physician-scientist leading the research team whose work has spurred worldwide attention to chimeric antigen receptor (CAR) technologies, and a trial participant whose leukemia remains in remission more than two and a half years after being treated with his own engineered cells – will explore the future of personalized cellular therapies.